HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiaqi Lu Selected Research

triphenylphosphonium

5/2022pH-redox responsive cascade-targeted liposomes to intelligently deliver doxorubicin prodrugs and lonidamine for glioma.
2/2022Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma.
6/2021Glucose and Triphenylphosphonium Co-Modified Redox-Sensitive Liposomes to Synergistically Treat Glioma with Doxorubicin and Lonidamine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiaqi Lu Research Topics

Disease

10Neoplasms (Cancer)
05/2022 - 09/2016
4Glioma (Gliomas)
05/2022 - 06/2021
4Alzheimer Disease (Alzheimer's Disease)
12/2021 - 01/2020
4Inflammation (Inflammations)
01/2021 - 01/2017
3Infections
12/2021 - 12/2012
3Experimental Arthritis
01/2021 - 09/2016
2Brain Neoplasms (Brain Tumor)
02/2022 - 06/2021
2Rheumatoid Arthritis
01/2021 - 11/2018
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2021
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 01/2017
2Osteoporosis
11/2018 - 09/2016
1Human Influenza (Influenza)
06/2022
1Sepsis (Septicemia)
06/2022
1Neoplasm Metastasis (Metastasis)
05/2022
1Mitochondrial Diseases (Mitochondrial Disease)
05/2022
1Bipolar Disorder (Manic Depressive Psychosis)
01/2022
1Schizophrenia (Dementia Praecox)
01/2022
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2022
1Substance-Related Disorders (Drug Abuse)
01/2022
1Gambling (Pathological Gambling)
01/2022
1Stomach Neoplasms (Stomach Cancer)
01/2021
1Metabolic Bone Diseases (Osteopenia)
01/2021
1Body Weight (Weight, Body)
01/2020
1Brain Ischemia (Cerebral Ischemia)
01/2020
1Dementia (Dementias)
01/2020
1Carcinogenesis
01/2020
1Non-alcoholic Fatty Liver Disease
01/2020
1Breast Neoplasms (Breast Cancer)
12/2019
1Hypersensitivity (Allergy)
05/2019
1Demyelinating Diseases (Demyelinating Disease)
07/2017
1Choriocarcinoma
03/2017
1Type 2 Diabetes Mellitus (MODY)
03/2017
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2017
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017
1Lymphatic Metastasis
01/2017

Drug/Important Bio-Agent (IBA)

4Liposomes (Liposome)IBA
05/2022 - 06/2021
4LigandsIBA
05/2022 - 09/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
05/2022 - 06/2021
3lonidamineIBA
05/2022 - 06/2021
3triphenylphosphoniumIBA
05/2022 - 06/2021
3Neuroprotective AgentsIBA
12/2021 - 01/2020
3Proteins (Proteins, Gene)FDA Link
12/2019 - 12/2012
2Glucose (Dextrose)FDA LinkGeneric
05/2022 - 06/2021
2Glutathione (Reduced Glutathione)IBA
05/2022 - 06/2021
2Amino AcidsFDA Link
01/2022 - 08/2020
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2020
2GlucocorticoidsIBA
01/2021 - 11/2018
2Prednisone (Sone)FDA LinkGeneric
01/2021 - 11/2018
2Therapeutic UsesIBA
01/2021 - 01/2020
2Insulin (Novolin)FDA Link
03/2017 - 03/2016
1PhytochemicalsIBA
06/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022
1tocophersolanIBA
05/2022
1ProdrugsIBA
05/2022
1AminesIBA
02/2022
1AmidesIBA
02/2022
1AcidsIBA
02/2022
1phenolic acidIBA
02/2022
1sigma Receptors (sigma Receptor)IBA
02/2022
1Dopamine (Intropin)FDA LinkGeneric
02/2022
1Transfer RNA (tRNA)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1DystrophinIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Illicit Drugs (Recreational Drugs)IBA
01/2022
1andrographolideIBA
12/2021
1Environmental BiomarkersIBA
12/2021
1DisulfidesIBA
06/2021
1salvianolateIBA
01/2021
1N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA
01/2021
1CytokinesIBA
01/2021
1Terpenes (Terpenoids)IBA
08/2020
1PolyketidesIBA
08/2020
1NF-kappa B (NF-kB)IBA
04/2020
1Chlorogenic AcidIBA
01/2020
1Biological ProductsIBA
01/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020
1Long Noncoding RNAIBA
01/2020
1theasinensin AIBA
01/2020
1tanshinoneIBA
01/2020
1QuercetinIBA
01/2020
1Triglycerides (Triacylglycerol)IBA
01/2020
1CyclinsIBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020
1HydrogelsIBA
01/2020
1Anthocyanins (Anthocyanin)IBA
01/2020
1AntioxidantsIBA
01/2020
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2019
1Small Interfering RNA (siRNA)IBA
05/2019
1QingkailingIBA
05/2019
1Actins (F Actin)IBA
05/2019
1CuprizoneIBA
07/2017
1Serum AlbuminIBA
01/2017
1VimentinIBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017

Therapy/Procedure

4Therapeutics
06/2021 - 01/2020
2Immunotherapy
01/2021 - 01/2021
1Combination Drug Therapy (Combination Chemotherapy)
05/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020
1Adjuvant Chemotherapy
03/2017